Department of Physical Medicine and Rehabilitation, Liege University Hospital Center, Liege, Belgium.
Department of Sport and Rehabilitation Sciences, University of Liege, Liege, Belgium.
Disabil Rehabil. 2022 Jan;44(1):13-23. doi: 10.1080/09638288.2020.1759703. Epub 2020 May 12.
Transcranial direct current stimulation (tDCS) has been extensively studied over the past 20 years to promote functional motor recovery after stroke. However, tDCS clinical relevance still needs to be determined. The present systematic review aims to determine whether tDCS applied to the primary motor cortex (M1) in stroke patients can have a positive effect on functional motor outcomes.
Two databases (Medline & Scopus) were searched for randomized, double-blinded, sham-controlled trials pertaining to the use of M1 tDCS on cerebral stroke patients, and its effects on validated functional motor outcomes. When data were provided, effect sizes were calculated. PROSPERO registration number: CRD42018108157.
46 studies ( = 1291 patients) met inclusion criteria. Overall study quality was good (7.69/10 on the PEDro scale). Over half (56.5%) the studies were on chronic stroke patients. There seemed to be a certain pattern of recurring parameters, but tDCS protocols still remain heterogeneous. Overall results were positive (71.7% of studies found that tDCS has positive results on functional motor outcomes). Effect-sizes ranged from 0 to 1.33. No severe adverse events were reported.
Despite heterogeneous stimulation parameters, outcomes and patient demographics, tDCS seems to be complementary to classical and novel rehabilitation approaches. With minimal adverse effects (if screening parameters are respected), none of which were serious, and a high potential to improve recovery when using optimal parameters (i.e.: 20 min of stimulation, at 2 mA with 25 or 35cm electrodes that are regularly humidified), tDCS could potentially be ready for clinical applications.Implications for RehabilitationtDCS could potentially be ready for clinical application.Evidence of very low to very high quality is available on the effectiveness of tDCS to improve motor control following stroke.This should with caution be focused on the primary motor cortex.
经颅直流电刺激(tDCS)在过去 20 年中得到了广泛研究,以促进中风后功能运动的恢复。然而,tDCS 的临床相关性仍需确定。本系统评价旨在确定刺激中风患者初级运动皮层(M1)的 tDCS 是否对功能运动结果有积极影响。
在 Medline 和 Scopus 两个数据库中搜索关于 M1 tDCS 应用于中风患者及其对验证后的功能运动结果的影响的随机、双盲、假对照试验。当提供数据时,计算了效应量。PROSPERO 注册号:CRD42018108157。
46 项研究(n=1291 名患者)符合纳入标准。总体研究质量良好(PEDro 量表评分为 7.69/10)。超过一半(56.5%)的研究是针对慢性中风患者。似乎存在一种重复出现的参数模式,但 tDCS 方案仍然存在异质性。总体结果是积极的(71.7%的研究发现 tDCS 对功能运动结果有积极影响)。效应量范围从 0 到 1.33。没有报告严重不良事件。
尽管刺激参数、结果和患者特征存在异质性,但 tDCS 似乎是对经典和新型康复方法的补充。在尊重筛选参数的情况下,tDCS 的不良反应最小(如果有),且在使用最佳参数(即:20 分钟刺激,2mA,使用定期加湿的 25 或 35cm 电极)时,具有提高恢复的高潜力,tDCS 可能已准备好临床应用。
tDCS 有可能准备好临床应用。现有非常低到非常高质量的证据表明 tDCS 可改善中风后的运动控制。这应该谨慎地集中在初级运动皮层上。